| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alanine:sodium symporter activity | 4.86e-07 | 4 | 100 | 3 | GO:0015655 | |
| GeneOntologyMolecularFunction | symporter activity | SLC12A6 SLC38A4 SLC24A3 SLC1A6 SLC12A5 SLC38A1 SLC38A2 SLC20A1 | 8.73e-07 | 150 | 100 | 8 | GO:0015293 |
| GeneOntologyMolecularFunction | alanine transmembrane transporter activity | 1.03e-06 | 16 | 100 | 4 | GO:0022858 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 1.85e-06 | 41 | 100 | 5 | GO:0015175 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 2.26e-06 | 119 | 100 | 7 | GO:0015294 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SLC38A4 SLC38A5 SLC24A3 SLC1A6 SLC38A1 SLC38A2 SLC20A1 SCN3A | 2.34e-06 | 171 | 100 | 8 | GO:0015081 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC12A6 SLC38A4 SLC38A5 SLC24A3 SLC1A6 SLC12A5 SLC38A1 SLC38A2 SLC20A1 ABCC8 | 2.73e-06 | 301 | 100 | 10 | GO:0022853 |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 4.87e-06 | 23 | 100 | 4 | GO:0005283 | |
| GeneOntologyMolecularFunction | neutral L-amino acid:sodium symporter activity | 6.70e-06 | 8 | 100 | 3 | GO:0005295 | |
| GeneOntologyMolecularFunction | L-glutamine transmembrane transporter activity | 1.00e-05 | 9 | 100 | 3 | GO:0015186 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 1.28e-05 | 29 | 100 | 4 | GO:0005416 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC12A6 SLC38A4 SLC38A5 SLC24A3 SLC1A6 SLC12A5 SLC38A1 SLC38A2 SLC20A1 | 1.79e-05 | 296 | 100 | 9 | GO:0015291 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC12A6 SLC38A4 SLC38A5 SLC24A3 SLC1A6 SLC12A5 SLC38A1 SLC38A2 SLC20A1 ABCC8 SCN3A | 2.13e-05 | 465 | 100 | 11 | GO:0046873 |
| GeneOntologyMolecularFunction | ammonium channel activity | 2.59e-05 | 12 | 100 | 3 | GO:0008519 | |
| GeneOntologyMolecularFunction | cAMP response element binding protein binding | 2.59e-05 | 12 | 100 | 3 | GO:0008140 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 2.75e-05 | 35 | 100 | 4 | GO:0005343 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 2.85e-05 | 71 | 100 | 5 | GO:0015179 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 5.40e-05 | 81 | 100 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 6.07e-05 | 83 | 100 | 5 | GO:0015101 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC12A6 SLC38A4 SLC38A5 SLC24A3 SLC1A6 RHAG SLC12A5 SLC38A1 SLC38A2 SLC20A1 ABCC8 SCN3A | 6.99e-05 | 627 | 100 | 12 | GO:0022890 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC12A6 ANO2 SLC38A4 SLC38A5 SLC24A3 SLC1A6 RHAG SLC12A5 SLC38A1 SLC38A2 SLC20A1 ABCC8 SCN3A | 1.04e-04 | 758 | 100 | 13 | GO:0015318 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC12A6 SLC38A4 SLC38A5 SLC24A3 SLC1A6 SLC12A5 SLC38A1 SLC38A2 SLC20A1 ABCC8 | 1.40e-04 | 477 | 100 | 10 | GO:0022804 |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.85e-04 | 105 | 100 | 5 | GO:0015171 | |
| GeneOntologyMolecularFunction | proline:sodium symporter activity | 2.46e-04 | 5 | 100 | 2 | GO:0005298 | |
| GeneOntologyMolecularFunction | MRF binding | 3.68e-04 | 6 | 100 | 2 | GO:0043426 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC12A6 SLC38A4 SLC38A5 SLC24A3 SLC1A6 SLC12A5 SLC38A1 SLC38A2 SLC20A1 ABCC8 SCN3A | 4.90e-04 | 664 | 100 | 11 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC12A6 ANO2 SLC38A4 SLC38A5 SLC24A3 SLC1A6 SLC12A5 SLC38A1 SLC38A2 SLC20A1 ABCC8 SCN3A | 6.04e-04 | 793 | 100 | 12 | GO:0015075 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 6.75e-04 | 582 | 100 | 10 | GO:0140297 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 8.37e-04 | 37 | 100 | 3 | GO:0043425 | |
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 8.74e-04 | 9 | 100 | 2 | GO:0015379 | |
| GeneOntologyMolecularFunction | L-serine transmembrane transporter activity | 8.74e-04 | 9 | 100 | 2 | GO:0015194 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 9.77e-04 | 39 | 100 | 3 | GO:0070325 | |
| GeneOntologyMolecularFunction | glycine transmembrane transporter activity | 1.09e-03 | 10 | 100 | 2 | GO:0015187 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic density | 1.33e-03 | 11 | 100 | 2 | GO:0098919 | |
| GeneOntologyMolecularFunction | gamma-catenin binding | 1.59e-03 | 12 | 100 | 2 | GO:0045295 | |
| GeneOntologyMolecularFunction | transporter activity | SLC12A6 ANO2 SLC38A4 SLC38A5 SLC24A3 ATP10B APOB SLC1A6 RHAG SLC12A5 SLC38A1 SLC38A2 SLC20A1 ABCC8 SCN3A | 1.85e-03 | 1289 | 100 | 15 | GO:0005215 |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic specialization | 1.87e-03 | 13 | 100 | 2 | GO:0098879 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 2.85e-03 | 16 | 100 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 3.12e-03 | 120 | 100 | 4 | GO:0008013 | |
| GeneOntologyMolecularFunction | polyubiquitin modification-dependent protein binding | 3.23e-03 | 59 | 100 | 3 | GO:0031593 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 3.80e-03 | 206 | 100 | 5 | GO:0140030 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 3.87e-03 | 207 | 100 | 5 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 3.95e-03 | 208 | 100 | 5 | GO:0005342 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 4.44e-03 | 66 | 100 | 3 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 4.44e-03 | 66 | 100 | 3 | GO:0001098 | |
| GeneOntologyMolecularFunction | basic amino acid transmembrane transporter activity | 4.45e-03 | 20 | 100 | 2 | GO:0015174 | |
| GeneOntologyMolecularFunction | acidic amino acid transmembrane transporter activity | 4.45e-03 | 20 | 100 | 2 | GO:0015172 | |
| GeneOntologyMolecularFunction | transcription factor binding | 4.47e-03 | 753 | 100 | 10 | GO:0008134 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 4.90e-03 | 21 | 100 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 5.87e-03 | 23 | 100 | 2 | GO:0015377 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC12A6 ANO2 SLC38A4 SLC38A5 SLC24A3 SLC1A6 RHAG SLC12A5 SLC38A1 SLC38A2 SLC20A1 ABCC8 SCN3A | 5.95e-03 | 1180 | 100 | 13 | GO:0022857 |
| GeneOntologyBiologicalProcess | L-glutamine import across plasma membrane | 1.00e-06 | 5 | 97 | 3 | GO:1903803 | |
| GeneOntologyBiologicalProcess | alanine transport | 1.34e-06 | 18 | 97 | 4 | GO:0032328 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | SLC12A6 SLC38A4 SLC38A5 SLC1A6 SLC12A5 SLC38A1 SLC38A2 ABCC8 DLG1 | 1.39e-06 | 230 | 97 | 9 | GO:0098739 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 6.26e-06 | 208 | 97 | 8 | GO:0035725 | |
| GeneOntologyBiologicalProcess | amino acid import across plasma membrane | 7.80e-06 | 58 | 97 | 5 | GO:0089718 | |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 9.23e-06 | 60 | 97 | 5 | GO:0015804 | |
| GeneOntologyBiologicalProcess | import into cell | DOCK1 SLC12A6 HSPG2 ITCH SLC38A4 SLC38A5 LRP1B SLC1A6 SLC12A5 SLC38A1 MAGI2 SLC38A2 ABCC8 MKLN1 LRP1 DLG1 CLINT1 | 9.80e-06 | 1074 | 97 | 17 | GO:0098657 |
| GeneOntologyBiologicalProcess | glutamine transport | 1.18e-05 | 10 | 97 | 3 | GO:0006868 | |
| GeneOntologyBiologicalProcess | L-amino acid transport | 1.20e-05 | 108 | 97 | 6 | GO:0015807 | |
| GeneOntologyBiologicalProcess | ammonium transmembrane transport | 2.79e-05 | 13 | 97 | 3 | GO:0072488 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 4.68e-05 | 275 | 97 | 8 | GO:0006814 | |
| GeneOntologyBiologicalProcess | L-alpha-amino acid transmembrane transport | 5.65e-05 | 87 | 97 | 5 | GO:1902475 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 5.65e-05 | 87 | 97 | 5 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 5.97e-05 | 88 | 97 | 5 | GO:0010232 | |
| GeneOntologyBiologicalProcess | serine import across plasma membrane | 6.55e-05 | 3 | 97 | 2 | GO:0098718 | |
| GeneOntologyBiologicalProcess | L-serine import across plasma membrane | 6.55e-05 | 3 | 97 | 2 | GO:1903812 | |
| GeneOntologyBiologicalProcess | amino acid import | 6.55e-05 | 3 | 97 | 2 | GO:0043090 | |
| GeneOntologyBiologicalProcess | positive regulation of CREB transcription factor activity | 7.82e-05 | 18 | 97 | 3 | GO:0032793 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | SP1 HSPG2 MATR3 AMBRA1 APOB SPECC1L BIRC6 LRP1B PHGDH XAB2 FOXD3 BRD4 DLG1 RPA1 | 8.46e-05 | 906 | 97 | 14 | GO:0043009 |
| GeneOntologyBiologicalProcess | potassium ion import across plasma membrane | 9.69e-05 | 51 | 97 | 4 | GO:1990573 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | SP1 HSPG2 MATR3 AMBRA1 APOB SPECC1L BIRC6 LRP1B PHGDH XAB2 FOXD3 BRD4 DLG1 RPA1 | 1.10e-04 | 929 | 97 | 14 | GO:0009792 |
| GeneOntologyBiologicalProcess | L-alanine transmembrane transport | 2.17e-04 | 5 | 97 | 2 | GO:1904557 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 2.58e-04 | 120 | 97 | 5 | GO:0003333 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | AKAP6 SLC12A6 ANO2 SLC38A4 SLC38A5 SLC24A3 RHAG SLC12A5 SLC38A1 SLC38A2 SLC20A1 ABCC8 SCN3A DLG1 | 2.81e-04 | 1017 | 97 | 14 | GO:0098660 |
| GeneOntologyBiologicalProcess | amino acid transport | 3.20e-04 | 195 | 97 | 6 | GO:0006865 | |
| GeneOntologyBiologicalProcess | embryo development | SP1 HSPG2 MATR3 AMBRA1 APOB SPECC1L REST BIRC6 LRP1B CREBBP PHGDH XAB2 FOXD3 BRD4 DLG1 ANKRD24 RPA1 | 3.58e-04 | 1437 | 97 | 17 | GO:0009790 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | AKAP6 SLC12A6 SLC38A4 SLC38A5 SLC24A3 RHAG SLC12A5 SLC38A1 SLC38A2 SLC20A1 ABCC8 SCN3A DLG1 | 3.76e-04 | 922 | 97 | 13 | GO:0098662 |
| MousePheno | intracranial hemorrhage | 2.48e-06 | 104 | 82 | 7 | MP:0001915 | |
| MousePheno | hemorrhage | CARM1 HSPG2 SAMD1 APC TAB2 APOB BIRC6 CREBBP PHGDH SLC12A5 PNPLA6 COG6 LRP1 ANKRD17 TP73 | 6.20e-06 | 664 | 82 | 15 | MP:0001914 |
| MousePheno | internal hemorrhage | CARM1 HSPG2 APC TAB2 BIRC6 CREBBP PNPLA6 COG6 LRP1 ANKRD17 TP73 | 1.52e-05 | 387 | 82 | 11 | MP:0001634 |
| MousePheno | abnormal vascular development | DOCK1 HSPG2 SAMD1 MATR3 BIRC6 CREBBP PHGDH PNPLA6 COG6 SLC20A1 KLF5 ANKRD17 | 7.11e-05 | 542 | 82 | 12 | MP:0000259 |
| MousePheno | abnormal blood circulation | CARM1 HSPG2 SAMD1 APC TAB2 APOB BIRC6 CREBBP PHGDH SLC12A5 PNPLA6 COG6 LRP1 ANKRD17 TP73 | 1.03e-04 | 845 | 82 | 15 | MP:0002128 |
| Domain | Aa_trans | 1.61e-06 | 17 | 98 | 4 | PF01490 | |
| Domain | AA_transpt_TM | 1.61e-06 | 17 | 98 | 4 | IPR013057 | |
| Domain | DHR-1_domain | 2.24e-05 | 11 | 98 | 3 | IPR027007 | |
| Domain | DHR_2 | 2.24e-05 | 11 | 98 | 3 | PS51651 | |
| Domain | DHR_1 | 2.24e-05 | 11 | 98 | 3 | PS51650 | |
| Domain | DHR-2 | 2.24e-05 | 11 | 98 | 3 | PF06920 | |
| Domain | DOCK | 2.24e-05 | 11 | 98 | 3 | IPR026791 | |
| Domain | DOCK_C | 2.24e-05 | 11 | 98 | 3 | IPR010703 | |
| Domain | DOCK-C2 | 2.24e-05 | 11 | 98 | 3 | PF14429 | |
| Domain | DHR-2 | 2.24e-05 | 11 | 98 | 3 | IPR027357 | |
| Domain | DUF5050 | 2.73e-05 | 2 | 98 | 2 | IPR032485 | |
| Domain | DUF5050 | 2.73e-05 | 2 | 98 | 2 | PF16472 | |
| Domain | LDLR_class-A_CS | 5.63e-05 | 40 | 98 | 4 | IPR023415 | |
| Domain | TORC_N | 8.15e-05 | 3 | 98 | 2 | IPR024783 | |
| Domain | TORC | 8.15e-05 | 3 | 98 | 2 | IPR024786 | |
| Domain | TORC_M | 8.15e-05 | 3 | 98 | 2 | IPR024784 | |
| Domain | TORC_C | 8.15e-05 | 3 | 98 | 2 | IPR024785 | |
| Domain | TORC_N | 8.15e-05 | 3 | 98 | 2 | PF12884 | |
| Domain | TORC_M | 8.15e-05 | 3 | 98 | 2 | PF12885 | |
| Domain | TORC_C | 8.15e-05 | 3 | 98 | 2 | PF12886 | |
| Domain | Ldl_recept_a | 9.00e-05 | 45 | 98 | 4 | PF00057 | |
| Domain | - | 9.82e-05 | 46 | 98 | 4 | 4.10.400.10 | |
| Domain | LDLRA_1 | 1.16e-04 | 48 | 98 | 4 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 1.26e-04 | 49 | 98 | 4 | IPR002172 | |
| Domain | LDLa | 1.26e-04 | 49 | 98 | 4 | SM00192 | |
| Domain | LDLRA_2 | 1.26e-04 | 49 | 98 | 4 | PS50068 | |
| Domain | KCL_cotranspt | 1.62e-04 | 4 | 98 | 2 | IPR000076 | |
| Domain | DOCK_N | 2.70e-04 | 5 | 98 | 2 | PF16172 | |
| Domain | DOCK_N | 2.70e-04 | 5 | 98 | 2 | IPR032376 | |
| Domain | Nuc_rcpt_coact | 4.03e-04 | 6 | 98 | 2 | IPR009110 | |
| Domain | Ubiquilin | 4.03e-04 | 6 | 98 | 2 | IPR015496 | |
| Domain | SLC12A_fam | 5.63e-04 | 7 | 98 | 2 | IPR004842 | |
| Domain | SLC12_C | 7.48e-04 | 8 | 98 | 2 | IPR018491 | |
| Domain | SLC12 | 7.48e-04 | 8 | 98 | 2 | PF03522 | |
| Domain | WW | 1.92e-03 | 47 | 98 | 3 | PF00397 | |
| Domain | WW | 2.04e-03 | 48 | 98 | 3 | SM00456 | |
| Domain | ARM-type_fold | 2.06e-03 | 339 | 98 | 7 | IPR016024 | |
| Domain | Ldl_recept_b | 2.38e-03 | 14 | 98 | 2 | PF00058 | |
| Domain | LDLRB | 2.38e-03 | 14 | 98 | 2 | PS51120 | |
| Domain | WW_DOMAIN_1 | 2.43e-03 | 51 | 98 | 3 | PS01159 | |
| Domain | WW_DOMAIN_2 | 2.43e-03 | 51 | 98 | 3 | PS50020 | |
| Domain | WW_dom | 2.57e-03 | 52 | 98 | 3 | IPR001202 | |
| Domain | LY | 2.74e-03 | 15 | 98 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.74e-03 | 15 | 98 | 2 | IPR000033 | |
| Domain | Guanylate_kinase_CS | 3.12e-03 | 16 | 98 | 2 | IPR020590 | |
| Domain | UBA-like | 4.63e-03 | 64 | 98 | 3 | IPR009060 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | SLC12A6 SLC38A4 SLC38A5 SLC24A3 SLC1A6 SLC12A5 SLC38A1 SLC38A2 SLC20A1 | 6.78e-09 | 108 | 77 | 9 | M823 |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | SLC12A6 SLC38A4 SLC38A5 SLC24A3 SLC1A6 SLC12A5 SLC38A1 SLC38A2 SLC20A1 | 7.36e-09 | 109 | 77 | 9 | MM15074 |
| Pathway | REACTOME_HEME_SIGNALING | 2.53e-07 | 49 | 77 | 6 | M41832 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC12A6 SLC38A4 SLC38A5 SLC24A3 SLC1A6 RHAG SLC12A5 SLC38A1 SLC38A2 SLC20A1 | 6.35e-07 | 238 | 77 | 10 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC12A6 SLC38A4 SLC38A5 SLC24A3 SLC1A6 RHAG SLC12A5 SLC38A1 SLC38A2 SLC20A1 | 9.59e-07 | 249 | 77 | 10 | M5988 |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 1.20e-05 | 55 | 77 | 5 | M27145 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 2.63e-05 | 32 | 77 | 4 | MM14957 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 2.99e-05 | 33 | 77 | 4 | M188 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 3.91e-05 | 70 | 77 | 5 | M938 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC12A6 ANO2 SLC38A4 SLC38A5 SLC24A3 ATP10B APOB SLC1A6 RHAG SLC12A5 SLC38A1 SLC38A2 SLC20A1 | 7.33e-05 | 681 | 77 | 13 | MM14985 |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 7.87e-05 | 42 | 77 | 4 | M27172 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 1.21e-04 | 18 | 77 | 3 | M26942 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC12A6 ANO2 SLC38A4 SLC38A5 SLC24A3 ATP10B APOB SLC1A6 RHAG SLC12A5 SLC38A1 SLC38A2 SLC20A1 | 1.60e-04 | 736 | 77 | 13 | M27287 |
| Pathway | REACTOME_MITOCHONDRIAL_BIOGENESIS | 1.77e-04 | 96 | 77 | 5 | M26973 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 2.27e-04 | 55 | 77 | 4 | M27001 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 4.17e-04 | 27 | 77 | 3 | M26943 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 6.08e-04 | 7 | 77 | 2 | M27339 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 6.08e-04 | 7 | 77 | 2 | MM15081 | |
| Pubmed | AKAP6 NCOA2 DOCK3 DCHS2 ITCH UBQLN4 APC LRP1B CREBBP XAB2 MAGI2 FAM120A SIPA1L1 MKLN1 LRP1 ZBTB5 DLG1 ANKRD24 EXOC1 LRBA ZNF292 | 8.93e-11 | 1285 | 100 | 21 | 35914814 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CRTC3 ITCH MATR3 APC CRTC1 TAB2 ITPRID2 SLC38A2 VPS13D MDN1 PI4KA BRD4 SIPA1L1 DOCK7 AGFG1 ANKRD17 CLINT1 | 4.11e-10 | 861 | 100 | 17 | 36931259 |
| Pubmed | CARM1 NCOA2 ITCH MATR3 APC SPECC1L SLC12A5 MAGI2 MDN1 FAM120A PI4KA SIPA1L1 DOCK7 LRP1 ANKRD17 DLG1 RPA1 | 2.22e-09 | 963 | 100 | 17 | 28671696 | |
| Pubmed | AKAP6 NCOA2 USP45 MATR3 APC CRTC1 TAB2 APOB SLC38A2 SLC20A1 PI4KA SIPA1L1 MKLN1 ANKRD17 DLG1 NUP188 RPA1 | 1.28e-08 | 1084 | 100 | 17 | 11544199 | |
| Pubmed | DOCK1 SP1 CRTC3 APC CRTC1 ITPRID2 SPECC1L CREBBP KIAA1549L AGFG1 ANKRD17 ANKRD24 | 1.67e-08 | 486 | 100 | 12 | 20936779 | |
| Pubmed | SAMD1 ITCH GNL3L AMBRA1 CREBBP PRPF40A PNPLA6 FAM120A ZFHX4 BRD4 SIPA1L1 SS18L1 LRP1 ANKRD17 NUP188 TP73 SON | 1.95e-08 | 1116 | 100 | 17 | 31753913 | |
| Pubmed | AKAP6 SLC12A6 HSPG2 ITCH GON4L TAB2 BIRC6 PHGDH FAM120A MKLN1 EXOC1 SON | 2.14e-08 | 497 | 100 | 12 | 23414517 | |
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 21733830 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 2.52e-08 | 232 | 100 | 9 | 25515538 | |
| Pubmed | SAMD1 UBQLN4 APC CRTC1 BIRC6 ZFHX4 BRD4 DOCK7 LRP1 ANKRD17 LRBA | 3.60e-08 | 418 | 100 | 11 | 34709266 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | DOCK1 DOCK3 PRUNE2 SP1 CRTC3 ITPRID2 KLF5 AGFG1 CLINT1 TP73 SON | 4.80e-08 | 430 | 100 | 11 | 35044719 |
| Pubmed | 8.57e-08 | 15 | 100 | 4 | 23506890 | ||
| Pubmed | 9.21e-08 | 4 | 100 | 3 | 17050538 | ||
| Pubmed | DOCK1 CARM1 APC TAB2 PRPF40A PHGDH SLC38A1 DOCK7 ANKRD17 DLG1 CLINT1 LRBA RPA1 | 1.30e-07 | 708 | 100 | 13 | 39231216 | |
| Pubmed | 2.03e-07 | 87 | 100 | 6 | 12465718 | ||
| Pubmed | ITCH GNL3L MATR3 BIRC6 PRPF40A XAB2 POLR3A MDN1 PNPLA6 FAM120A PI4KA ANKRD17 EXOC1 CLINT1 NUP188 LRBA | 2.25e-07 | 1168 | 100 | 16 | 19946888 | |
| Pubmed | ROS inhibits RORα degradation by decreasing its arginine methylation in liver cancer. | 2.30e-07 | 5 | 100 | 3 | 36114756 | |
| Pubmed | 2.30e-07 | 5 | 100 | 3 | 18703994 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DOCK1 NCOA2 PRUNE2 SLC12A6 ITCH GNL3L UVSSA ADGRV1 CREBBP PNPLA6 FAM120A ABCC8 MKLN1 LRP1 ANKRD17 DLG1 ANKRD24 LRBA | 2.30e-07 | 1489 | 100 | 18 | 28611215 |
| Pubmed | AKAP6 DGCR2 UVSSA MATR3 AMBRA1 CRTC1 ADGRV1 SLC38A2 ZBTB5 ANKRD17 NUP188 | 3.80e-07 | 529 | 100 | 11 | 14621295 | |
| Pubmed | 4.58e-07 | 6 | 100 | 3 | 15731352 | ||
| Pubmed | NCOA2 MATR3 SPECC1L CREBBP PRPF40A PHGDH BRD4 DOCK7 DLG1 CLINT1 LRBA | 5.48e-07 | 549 | 100 | 11 | 38280479 | |
| Pubmed | MATR3 APC TAB2 PRPF40A PHGDH MDN1 FAM120A DOCK7 MKLN1 DLG1 EXOC1 RPA1 ALPK2 | 5.87e-07 | 809 | 100 | 13 | 32129710 | |
| Pubmed | 5.87e-07 | 104 | 100 | 6 | 9205841 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GNL3L MATR3 APOB PRPF40A PHGDH POLR3A SLC38A1 SLC38A2 MDN1 FAM120A PI4KA DOCK7 CLINT1 NUP188 CHST2 RPA1 MGAM2 | 6.25e-07 | 1425 | 100 | 17 | 30948266 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | CARM1 NCOA2 CRTC3 MATR3 CREBBP PRPF40A PHGDH PNPLA6 ANKRD17 NUP188 | 8.39e-07 | 457 | 100 | 10 | 32344865 |
| Pubmed | 1.28e-06 | 8 | 100 | 3 | 31570606 | ||
| Pubmed | 1.33e-06 | 274 | 100 | 8 | 34244482 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | NCOA2 SP1 APC ZNF200 REST CREBBP XAB2 POLR3A SS18L1 GMEB1 ZBTB5 TP73 ZNF292 | 1.44e-06 | 877 | 100 | 13 | 20211142 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ITCH GNL3L MATR3 AMBRA1 BIRC6 CREBBP PHGDH POLR3A MDN1 PNPLA6 FAM120A PI4KA ANKRD17 EXOC1 RPA1 SON | 1.56e-06 | 1353 | 100 | 16 | 29467282 |
| Pubmed | Amino acid transport across mammalian intestinal and renal epithelia. | 1.91e-06 | 31 | 100 | 4 | 18195088 | |
| Pubmed | 1.91e-06 | 9 | 100 | 3 | 16344550 | ||
| Pubmed | Altered placental function of 11beta-hydroxysteroid dehydrogenase 2 knockout mice. | 1.91e-06 | 9 | 100 | 3 | 18845627 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 2.34e-06 | 398 | 100 | 9 | 35016035 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SP1 MATR3 ITPRID2 REST PRPF40A MDN1 PNPLA6 BRD4 SIPA1L1 ANKRD17 DLG1 SON | 2.38e-06 | 774 | 100 | 12 | 15302935 |
| Pubmed | APC APOB SPECC1L BIRC6 SLC38A1 SLC38A2 ARL1 PI4KA DOCK7 DLG1 CLINT1 LRBA | 2.48e-06 | 777 | 100 | 12 | 35844135 | |
| Pubmed | GNL3L APC GON4L AMBRA1 XAB2 POLR3A ARL1 FAM120A DOCK7 ANKRD17 DLG1 | 2.81e-06 | 650 | 100 | 11 | 38777146 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 2.98e-06 | 410 | 100 | 9 | 26949251 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | SAMD1 GNL3L MATR3 APOB ITPRID2 SPECC1L PRPF40A PHGDH FAM120A DOCK7 CLINT1 RPA1 SON | 3.41e-06 | 949 | 100 | 13 | 36574265 |
| Pubmed | 4.98e-06 | 12 | 100 | 3 | 36497119 | ||
| Pubmed | SAMD1 GNL3L APC GON4L CRTC1 ITPRID2 SPECC1L PHGDH XAB2 MDN1 PNPLA6 PI4KA SIPA1L1 ANKRD17 DLG1 SON | 5.67e-06 | 1497 | 100 | 16 | 31527615 | |
| Pubmed | CARM1 SP1 SAMD1 MATR3 REST BIRC6 XAB2 SLC38A2 ARL1 SLC20A1 BRD4 TAS1R1 ANKRD17 NUP188 ZNF292 | 5.91e-06 | 1327 | 100 | 15 | 32694731 | |
| Pubmed | 6.00e-06 | 41 | 100 | 4 | 8724849 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | USP45 ITCH APC AMBRA1 POLR3A SIPA1L1 SS18L1 DOCK7 LRP1 ANKRD17 DLG1 CLINT1 NUP188 | 6.33e-06 | 1005 | 100 | 13 | 19615732 |
| Pubmed | NCOA2 SP1 REST BIRC6 CREBBP FOXD3 RNF113B KLF5 BRD4 GMEB1 ZNF292 | 6.40e-06 | 709 | 100 | 11 | 22988430 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MATR3 ITPRID2 SPECC1L PRPF40A PHGDH XAB2 MDN1 SLC20A1 PI4KA DOCK7 NUP188 RPA1 SON | 7.73e-06 | 1024 | 100 | 13 | 24711643 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | APC SPECC1L XAB2 FAM120A DOCK7 AGFG1 ANKRD17 EXOC1 CLINT1 SON ZNF292 | 7.79e-06 | 724 | 100 | 11 | 36232890 |
| Pubmed | 8.18e-06 | 591 | 100 | 10 | 15231748 | ||
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 8.18e-06 | 2 | 100 | 2 | 15963947 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 23185543 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 11279015 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 20528922 | ||
| Pubmed | The APC-hDLG complex negatively regulates cell cycle progression from the G0/G1 to S phase. | 8.18e-06 | 2 | 100 | 2 | 10656683 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 32164327 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 20516639 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 10692587 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 32513985 | ||
| Pubmed | Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK. | 8.18e-06 | 2 | 100 | 2 | 23531613 | |
| Pubmed | Transcriptional control of KCNQ channel genes and the regulation of neuronal excitability. | 8.18e-06 | 2 | 100 | 2 | 20926649 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 23408887 | ||
| Pubmed | Binding of APC to the human homolog of the Drosophila discs large tumor suppressor protein. | 8.18e-06 | 2 | 100 | 2 | 8638125 | |
| Pubmed | Control of CBP co-activating activity by arginine methylation. | 8.18e-06 | 2 | 100 | 2 | 12374746 | |
| Pubmed | Molecular basis for the recognition of adenomatous polyposis coli by the Discs Large 1 protein. | 8.18e-06 | 2 | 100 | 2 | 21858148 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 12351636 | ||
| Pubmed | 8.20e-06 | 14 | 100 | 3 | 12432077 | ||
| Pubmed | GNL3L MATR3 APOB SPECC1L PRPF40A PHGDH XAB2 ARL1 FAM120A DOCK7 ANKRD17 CLINT1 PIPSL RPA1 SON | 8.72e-06 | 1371 | 100 | 15 | 36244648 | |
| Pubmed | 1.19e-05 | 102 | 100 | 5 | 9734811 | ||
| Pubmed | 1.37e-05 | 105 | 100 | 5 | 30280653 | ||
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 1.41e-05 | 180 | 100 | 6 | 30110629 | |
| Pubmed | NCOA2 SP1 HSPG2 MATR3 GON4L R3HDM2 CREBBP PRPF40A FAM120A ZFHX4 KLF5 SS18L1 GMEB1 ANKRD17 RPA1 | 1.42e-05 | 1429 | 100 | 15 | 35140242 | |
| Pubmed | SLC12A6 MATR3 APC SPECC1L PRPF40A PHGDH SLC12A5 MAGI2 PNPLA6 FAM120A PI4KA SIPA1L1 DOCK7 DLG1 EXOC1 | 1.44e-05 | 1431 | 100 | 15 | 37142655 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | ITCH GNL3L MATR3 ITPRID2 SPECC1L PHGDH XAB2 PNPLA6 FAM120A SIPA1L1 DOCK7 ANKRD17 DLG1 CLINT1 | 1.47e-05 | 1257 | 100 | 14 | 36526897 |
| Pubmed | 1.52e-05 | 17 | 100 | 3 | 19183483 | ||
| Pubmed | 1.57e-05 | 52 | 100 | 4 | 26590417 | ||
| Pubmed | 1.82e-05 | 18 | 100 | 3 | 31917811 | ||
| Pubmed | 1.93e-05 | 285 | 100 | 7 | 34369648 | ||
| Pubmed | MATR3 ITPRID2 SPECC1L PRPF40A PI4KA DOCK7 DLG1 CLINT1 NUP188 RPA1 | 2.11e-05 | 660 | 100 | 10 | 32780723 | |
| Pubmed | 2.45e-05 | 534 | 100 | 9 | 35032548 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 14690606 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 20298593 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 22252133 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 11713257 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 22434720 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 10894151 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 24121173 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 23168245 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 30138216 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 25294805 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 19096009 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 18696186 | ||
| Pubmed | Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma. | 2.45e-05 | 3 | 100 | 2 | 28438292 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 22086197 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 14536081 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 21948504 | ||
| Pubmed | Characterization of BRD4 during mammalian postmeiotic sperm development. | 2.45e-05 | 3 | 100 | 2 | 25691659 | |
| Pubmed | Transcriptional activation of REST by Sp1 in Huntington's disease models. | 2.45e-05 | 3 | 100 | 2 | 21179468 | |
| Pubmed | Dendrite development regulated by CREST, a calcium-regulated transcriptional activator. | 2.45e-05 | 3 | 100 | 2 | 14716005 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 19435907 | ||
| Pubmed | The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73. | 2.45e-05 | 3 | 100 | 2 | 17110958 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 27402217 | ||
| Interaction | YWHAH interactions | NCOA2 CRTC3 MATR3 APC CRTC1 TAB2 R3HDM2 ITPRID2 SPECC1L CREBBP SLC38A2 ARL1 VPS13D PI4KA BRD4 SIPA1L1 DOCK7 AGFG1 ANKRD17 CLINT1 LRBA RPA1 | 1.40e-08 | 1102 | 99 | 22 | int:YWHAH |
| Interaction | YWHAG interactions | CRTC3 ITCH MATR3 APC CRTC1 TAB2 R3HDM2 ITPRID2 SPECC1L PRPF40A SLC38A2 VPS13D MDN1 PI4KA SIPA1L1 DOCK7 AGFG1 ANKRD17 CLINT1 LRBA RPA1 SON | 1.27e-07 | 1248 | 99 | 22 | int:YWHAG |
| Interaction | HDAC1 interactions | SP1 MATR3 UBQLN4 APC GON4L CRTC1 TAB2 REST BIRC6 CREBBP POLR3A ZFHX4 KLF5 BRD4 DOCK7 ZBTB5 ANKRD17 LRBA RPA1 TP73 | 3.62e-07 | 1108 | 99 | 20 | int:HDAC1 |
| Interaction | HDAC2 interactions | SP1 HSPG2 CRTC3 MATR3 UBQLN4 REST CREBBP POLR3A KLF5 BRD4 SS18L1 AGFG1 ANKRD17 CLINT1 LRBA RPA1 TP73 | 9.82e-07 | 865 | 99 | 17 | int:HDAC2 |
| Interaction | EGLN3 interactions | CARM1 NCOA2 CRTC3 APC AMBRA1 TAB2 BIRC6 CREBBP PHGDH POLR3A PNPLA6 KLF5 PI4KA BRD4 DOCK7 MKLN1 ZBTB5 ANKRD17 CLINT1 NUP188 PIPSL | 1.03e-06 | 1296 | 99 | 21 | int:EGLN3 |
| Interaction | RORA interactions | 1.30e-06 | 39 | 99 | 5 | int:RORA | |
| Interaction | YWHAQ interactions | CRTC3 ITCH MATR3 UBQLN4 APC CRTC1 TAB2 R3HDM2 ITPRID2 SPECC1L ARL1 VPS13D BRD4 SIPA1L1 DOCK7 AGFG1 ANKRD17 LRBA RPA1 | 1.83e-06 | 1118 | 99 | 19 | int:YWHAQ |
| Interaction | KCNA3 interactions | DOCK1 CARM1 NCOA2 APC TAB2 SPECC1L PRPF40A PHGDH SLC38A1 SIPA1L1 DOCK7 ANKRD17 DLG1 CLINT1 LRBA RPA1 | 5.05e-06 | 871 | 99 | 16 | int:KCNA3 |
| Interaction | RCOR1 interactions | SP1 SAMD1 MATR3 APC REST BIRC6 ZFHX4 BRD4 DOCK7 ZBTB5 ANKRD17 LRBA | 5.51e-06 | 494 | 99 | 12 | int:RCOR1 |
| Interaction | PHF21A interactions | 7.29e-06 | 343 | 99 | 10 | int:PHF21A | |
| Interaction | TRIM66 interactions | 7.75e-06 | 205 | 99 | 8 | int:TRIM66 | |
| Interaction | FKBP15 interactions | 9.35e-06 | 99 | 99 | 6 | int:FKBP15 | |
| Interaction | SMARCE1 interactions | 1.20e-05 | 287 | 99 | 9 | int:SMARCE1 | |
| Interaction | SMAD3 interactions | SP1 ITCH UBQLN4 APOB CREBBP MAGI2 KLF5 SS18L1 GMEB1 RPA1 TP73 | 1.23e-05 | 447 | 99 | 11 | int:SMAD3 |
| Interaction | SOX2 interactions | NCOA2 ITCH MATR3 ITPRID2 SPECC1L PHGDH MDN1 FAM120A ZFHX4 KLF5 PI4KA SIPA1L1 DOCK7 MKLN1 ZBTB5 ANKRD17 CLINT1 RPA1 TP73 ZNF292 | 1.62e-05 | 1422 | 99 | 20 | int:SOX2 |
| Interaction | USP7 interactions | DOCK3 SP1 UVSSA MATR3 APC GON4L CREBBP PRPF40A PHGDH FOXD3 MDN1 KIAA1549L SLC20A1 BRD4 SCN3A DOCK7 LRBA RPA1 LRRC73 | 1.84e-05 | 1313 | 99 | 19 | int:USP7 |
| Interaction | JUN interactions | 1.96e-05 | 470 | 99 | 11 | int:JUN | |
| Interaction | RXRA interactions | 2.01e-05 | 169 | 99 | 7 | int:RXRA | |
| Interaction | AKAP1 interactions | DOCK3 TAB2 R3HDM2 BIRC6 VPS13D MDN1 FAM120A PI4KA NUP188 RPA1 TP73 | 3.66e-05 | 503 | 99 | 11 | int:AKAP1 |
| Interaction | WWTR1 interactions | NCOA2 SPECC1L CREBBP PRPF40A KLF5 BRD4 DOCK7 DLG1 CLINT1 LRBA | 4.32e-05 | 422 | 99 | 10 | int:WWTR1 |
| Interaction | EP300 interactions | CARM1 NCOA2 SP1 MATR3 CRTC1 BIRC6 CREBBP PRPF40A PHGDH XAB2 KLF5 BRD4 SS18L1 DOCK7 ZBTB5 CLINT1 RPA1 TP73 SON | 4.50e-05 | 1401 | 99 | 19 | int:EP300 |
| Interaction | KDM1A interactions | CARM1 SAMD1 UBQLN4 APC CRTC1 BIRC6 ZFHX4 BRD4 DOCK7 LRP1 ANKRD17 EXOC1 LRBA RPA1 TP73 | 5.35e-05 | 941 | 99 | 15 | int:KDM1A |
| Interaction | RHOB interactions | DOCK1 SLC12A6 ITCH GNL3L SLC38A5 PHGDH SLC38A1 SLC38A2 MDN1 PI4KA SIPA1L1 DOCK7 AGFG1 DLG1 | 6.06e-05 | 840 | 99 | 14 | int:RHOB |
| Interaction | SMARCC2 interactions | 6.07e-05 | 353 | 99 | 9 | int:SMARCC2 | |
| Interaction | C2CD4B interactions | 6.40e-05 | 44 | 99 | 4 | int:C2CD4B | |
| Interaction | GTF2B interactions | 6.93e-05 | 141 | 99 | 6 | int:GTF2B | |
| Interaction | NCOR1 interactions | 7.52e-05 | 363 | 99 | 9 | int:NCOR1 | |
| Interaction | SMARCB1 interactions | 7.68e-05 | 364 | 99 | 9 | int:SMARCB1 | |
| Interaction | N4BP2 interactions | 7.74e-05 | 89 | 99 | 5 | int:N4BP2 | |
| Interaction | AR interactions | NCOA2 SP1 MATR3 TAB2 ITPRID2 CREBBP PRPF40A PHGDH XAB2 MDN1 KLF5 BRD4 NUP188 RPA1 SON | 9.68e-05 | 992 | 99 | 15 | int:AR |
| Interaction | MTTP interactions | 1.05e-04 | 19 | 99 | 3 | int:MTTP | |
| Interaction | TNIK interactions | 1.09e-04 | 381 | 99 | 9 | int:TNIK | |
| Interaction | SLX4 interactions | USP45 MATR3 CREBBP PHGDH XAB2 MDN1 BRD4 ZBTB5 CLINT1 NUP188 RPA1 | 1.15e-04 | 572 | 99 | 11 | int:SLX4 |
| Interaction | ERG interactions | 1.16e-04 | 223 | 99 | 7 | int:ERG | |
| Interaction | EWSR1 interactions | PRUNE2 CRTC3 ITCH MATR3 REST LRP1B CREBBP PRPF40A XAB2 POLR3A BRD4 CLINT1 RPA1 ZNF292 | 1.35e-04 | 906 | 99 | 14 | int:EWSR1 |
| Interaction | CREBBP interactions | CARM1 NCOA2 SP1 APC CRTC1 CREBBP KLF5 BRD4 SS18L1 GMEB1 TP73 | 1.72e-04 | 599 | 99 | 11 | int:CREBBP |
| Interaction | SMG7 interactions | 1.77e-04 | 319 | 99 | 8 | int:SMG7 | |
| Interaction | GLDC interactions | 1.85e-04 | 321 | 99 | 8 | int:GLDC | |
| Interaction | MAP1LC3A interactions | 1.88e-04 | 241 | 99 | 7 | int:MAP1LC3A | |
| Interaction | ELMO2 interactions | 1.90e-04 | 58 | 99 | 4 | int:ELMO2 | |
| Interaction | YTHDC1 interactions | SLC12A6 POLR3A SLC12A5 ZNF320 FAM120A BRD4 PIPSL RPA1 ZNF292 | 2.14e-04 | 417 | 99 | 9 | int:YTHDC1 |
| Interaction | NTN5 interactions | 2.16e-04 | 24 | 99 | 3 | int:NTN5 | |
| Interaction | BAG2 interactions | NCOA2 SLC12A6 SP1 AMBRA1 TAB2 CREBBP XAB2 VPS13D BRD4 DOCK7 RPA1 | 2.39e-04 | 622 | 99 | 11 | int:BAG2 |
| Interaction | NUP35 interactions | NCOA2 CRTC3 MATR3 CREBBP PRPF40A PHGDH PNPLA6 ANKRD17 NUP188 | 2.42e-04 | 424 | 99 | 9 | int:NUP35 |
| Interaction | MYO19 interactions | 2.46e-04 | 252 | 99 | 7 | int:MYO19 | |
| Interaction | POLD1 interactions | 2.57e-04 | 337 | 99 | 8 | int:POLD1 | |
| Interaction | CCNA2 interactions | 2.88e-04 | 183 | 99 | 6 | int:CCNA2 | |
| Interaction | FMR1 interactions | 3.05e-04 | 536 | 99 | 10 | int:FMR1 | |
| Interaction | LATS1 interactions | 3.17e-04 | 440 | 99 | 9 | int:LATS1 | |
| Interaction | MKI67 interactions | SP1 SAMD1 GNL3L KRT73 ARL1 PI4KA BRD4 SIPA1L1 DOCK7 RPA1 SON | 3.38e-04 | 648 | 99 | 11 | int:MKI67 |
| Interaction | CD79B interactions | 3.40e-04 | 122 | 99 | 5 | int:CD79B | |
| Interaction | TTC7B interactions | 3.45e-04 | 28 | 99 | 3 | int:TTC7B | |
| Interaction | ZFPL1 interactions | 3.62e-04 | 448 | 99 | 9 | int:ZFPL1 | |
| Interaction | MYCBP2 interactions | 3.64e-04 | 355 | 99 | 8 | int:MYCBP2 | |
| Interaction | UBE2I interactions | CARM1 MATR3 UBQLN4 TAB2 SPECC1L CREBBP PRPF40A KLF5 BRD4 GMEB1 TP73 | 3.66e-04 | 654 | 99 | 11 | int:UBE2I |
| Interaction | MSH6 interactions | 3.82e-04 | 271 | 99 | 7 | int:MSH6 | |
| Interaction | MDM2 interactions | SP1 CRTC3 ITCH GNL3L UBQLN4 ZNF200 APOB REST CREBBP ANKRD17 TP73 | 3.85e-04 | 658 | 99 | 11 | int:MDM2 |
| Interaction | RPA4 interactions | 3.86e-04 | 452 | 99 | 9 | int:RPA4 | |
| Interaction | CTNNB1 interactions | CARM1 NCOA2 SP1 MATR3 APC SPECC1L CREBBP PHGDH MAGI2 KLF5 BRD4 SIPA1L1 DLG1 RPA1 | 4.06e-04 | 1009 | 99 | 14 | int:CTNNB1 |
| Interaction | PSME1 interactions | 4.08e-04 | 274 | 99 | 7 | int:PSME1 | |
| Interaction | SRCAP interactions | 4.09e-04 | 127 | 99 | 5 | int:SRCAP | |
| Interaction | RAB4A interactions | 4.18e-04 | 457 | 99 | 9 | int:RAB4A | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 4.11e-05 | 423 | 100 | 7 | chr12q13 | |
| Cytoband | 12q13.3 | 1.94e-04 | 51 | 100 | 3 | 12q13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 3.64e-04 | 797 | 100 | 8 | chr19p13 | |
| GeneFamily | Solute carriers | SLC12A6 SLC38A4 SLC38A5 SLC24A3 SLC1A6 RHAG SLC12A5 SLC38A1 SLC38A2 SLC20A1 | 3.55e-06 | 395 | 72 | 10 | 752 |
| GeneFamily | Ubiquilin family | 1.55e-04 | 5 | 72 | 2 | 783 | |
| GeneFamily | Low density lipoprotein receptors | 1.19e-03 | 13 | 72 | 2 | 634 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.05e-03 | 17 | 72 | 2 | 486 | |
| GeneFamily | EF-hand domain containing|Nucleotide excision repair|Transcription and export complex 2 | 2.30e-03 | 18 | 72 | 2 | 1269 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 4.78e-03 | 26 | 72 | 2 | 904 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK1 NCOA2 ITCH APC TAB2 R3HDM2 SPECC1L CREBBP MDN1 SIPA1L1 MKLN1 AGFG1 ANKRD17 DLG1 CLINT1 SON ZNF292 | 2.45e-08 | 856 | 100 | 17 | M4500 |
| Coexpression | SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP | 3.27e-06 | 27 | 100 | 4 | M4447 | |
| Coexpression | HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN | 7.27e-06 | 70 | 100 | 5 | M13658 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP | 1.08e-05 | 197 | 100 | 7 | M7403 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | 3.96e-05 | 429 | 100 | 9 | M29 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | DOCK3 SLC24A3 LRP1B PTPRT SLC12A5 SLC38A1 KIAA1549L ZFHX4 SS18L1 SCN3A ZNF292 | 7.77e-05 | 703 | 100 | 11 | M39070 |
| Coexpression | GSE3982_NEUTROPHIL_VS_BASOPHIL_UP | 1.08e-04 | 196 | 100 | 6 | M5524 | |
| Coexpression | GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_DN | 1.14e-04 | 198 | 100 | 6 | M7620 | |
| Coexpression | GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_UP | 1.17e-04 | 199 | 100 | 6 | M5365 | |
| Coexpression | GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP | 1.20e-04 | 200 | 100 | 6 | M9449 | |
| Coexpression | GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_DN | 1.20e-04 | 200 | 100 | 6 | M8602 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_DN | 1.20e-04 | 200 | 100 | 6 | M3969 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | PRUNE2 HSPG2 GNL3L SLC24A3 TAB2 R3HDM2 CREBBP SLC38A1 SLC38A2 KLF5 SIPA1L1 ANKRD17 CLINT1 | 1.21e-04 | 1009 | 100 | 13 | M157 |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | 1.24e-04 | 389 | 100 | 8 | M39102 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | ITCH GNL3L APC REST FAM120A SLC20A1 ANKRD17 DLG1 CLINT1 CHST2 RPA1 ZNF292 | 1.24e-05 | 564 | 99 | 12 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 6.35e-10 | 196 | 100 | 9 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 9.87e-09 | 186 | 100 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-08 | 198 | 100 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.67e-08 | 199 | 100 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.74e-07 | 193 | 100 | 7 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 3.37e-07 | 199 | 100 | 7 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 7.02e-07 | 138 | 100 | 6 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-06 | 163 | 100 | 6 | 360cd65decda24853124f33a174f5224d7f3ce23 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-06 | 163 | 100 | 6 | b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-06 | 189 | 100 | 6 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 4.77e-06 | 192 | 100 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.92e-06 | 193 | 100 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 5.86e-06 | 199 | 100 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.86e-06 | 199 | 100 | 6 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.86e-06 | 199 | 100 | 6 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.86e-06 | 199 | 100 | 6 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 5.86e-06 | 199 | 100 | 6 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.86e-06 | 199 | 100 | 6 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Malignant_Peripheral_Nerve_Sheath_Tumors|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.79e-05 | 143 | 100 | 5 | d1c8e15a8ae2094de2919e99188f9211b78c5abf | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 160 | 100 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 160 | 100 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.16e-05 | 161 | 100 | 5 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | Int-URO-Myeloid-tDC|Int-URO / Disease, Lineage and Cell Type | 3.55e-05 | 165 | 100 | 5 | 9803c3db6cdcf925bea7d9c382bf4fd05acf3509 | |
| ToppCell | 15-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 3.55e-05 | 165 | 100 | 5 | 531804467601e1ee1f771cffa21501f6d464ae10 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 169 | 100 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 3'_v3-bone_marrow-Mast-Mast_cell_lympho|bone_marrow / Manually curated celltypes from each tissue | 4.09e-05 | 170 | 100 | 5 | 4dedf482cd4521b3f87d2b5ae80f7a3ea8686a15 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.09e-05 | 170 | 100 | 5 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Lymphatic_ECs|Endothelial_cells / Location, Cell class and cell subclass | 4.82e-05 | 176 | 100 | 5 | 42541dfe20eb29625d47c0bb79bf3c21a2460340 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.96e-05 | 177 | 100 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-05 | 182 | 100 | 5 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-05 | 182 | 100 | 5 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 184 | 100 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 184 | 100 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 184 | 100 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 6.11e-05 | 185 | 100 | 5 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 6.27e-05 | 186 | 100 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 191 | 100 | 5 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.11e-05 | 191 | 100 | 5 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 191 | 100 | 5 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 191 | 100 | 5 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.65e-05 | 194 | 100 | 5 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.03e-05 | 196 | 100 | 5 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.03e-05 | 196 | 100 | 5 | a9157809122e6fc5783a291522f103bef30943e4 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.03e-05 | 196 | 100 | 5 | 5bb8653af62334ded8aad48b24b64d7b54bc3cd5 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-Plasmablast|Influenza_Severe / Disease, condition lineage and cell class | 8.22e-05 | 197 | 100 | 5 | 9108edafbf5744ed65f556bcbbf819a9b71176a9 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Lymphatic|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 8.62e-05 | 199 | 100 | 5 | 88f33b8dcd837abfa1d12c28719e073a7da6e979 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.62e-05 | 199 | 100 | 5 | 64b19aff72e2a109cb5857cb248bd4712dd49b43 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 8.62e-05 | 199 | 100 | 5 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 8.62e-05 | 199 | 100 | 5 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 8.62e-05 | 199 | 100 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.62e-05 | 199 | 100 | 5 | 2b9e1e069b36b3a61cc3e384f4523687b0e03905 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.83e-05 | 200 | 100 | 5 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.83e-05 | 200 | 100 | 5 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.83e-05 | 200 | 100 | 5 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| Drug | AC1L2GOW | 1.48e-06 | 20 | 98 | 4 | CID000046762 | |
| Drug | sulfamate | 3.57e-06 | 54 | 98 | 5 | CID000005987 | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 2.25e-05 | 196 | 98 | 7 | 3568_DN | |
| Drug | Carisoprodol [78-44-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | 2.25e-05 | 196 | 98 | 7 | 6610_DN | |
| Drug | Doxylamine succinate [562-10-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 2.25e-05 | 196 | 98 | 7 | 4819_DN | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.25e-05 | 196 | 98 | 7 | 2889_DN | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 2.32e-05 | 197 | 98 | 7 | 6796_UP | |
| Drug | Nitrendipine [39562-70-4]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.40e-05 | 198 | 98 | 7 | 5405_DN | |
| Drug | Cefixime [79350-37-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 2.48e-05 | 199 | 98 | 7 | 4390_DN | |
| Drug | MeAIB | 3.19e-05 | 42 | 98 | 4 | CID000095739 | |
| Disease | epilepsy (implicated_via_orthology) | 1.01e-06 | 163 | 95 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | Schizophrenia | DGCR2 SP1 APC AMBRA1 REST SLC1A6 SLC12A5 MAGI2 SLC38A2 KLF5 PI4KA LRP1 DLG1 | 5.13e-06 | 883 | 95 | 13 | C0036341 |
| Disease | gallbladder cancer (is_implicated_in) | 9.03e-06 | 13 | 95 | 3 | DOID:3121 (is_implicated_in) | |
| Disease | adenoma (is_implicated_in) | 1.03e-05 | 2 | 95 | 2 | DOID:657 (is_implicated_in) | |
| Disease | AMYOTROPHIC LATERAL SCLEROSIS 1 | 2.07e-05 | 50 | 95 | 4 | C1862939 | |
| Disease | triglycerides in very small VLDL measurement | 7.01e-05 | 68 | 95 | 4 | EFO_0022144 | |
| Disease | Colorectal Carcinoma | 8.94e-05 | 702 | 95 | 10 | C0009402 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 2.57e-04 | 95 | 95 | 4 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | apolipoprotein B measurement | 2.92e-04 | 663 | 95 | 9 | EFO_0004615 | |
| Disease | Moyamoya disease | 2.93e-04 | 40 | 95 | 3 | MONDO_0016820 | |
| Disease | Adenoid Cystic Carcinoma | 3.12e-04 | 100 | 95 | 4 | C0010606 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 3.24e-04 | 101 | 95 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 3.63e-04 | 43 | 95 | 3 | EFO_0022290 | |
| Disease | Abnormality of the face | 3.64e-04 | 9 | 95 | 2 | C4025871 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 3.90e-04 | 106 | 95 | 4 | EFO_0008317, EFO_0008596 | |
| Disease | saturated fatty acids measurement | 4.16e-04 | 45 | 95 | 3 | EFO_0022304 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement | 4.33e-04 | 109 | 95 | 4 | EFO_0004639, EFO_0008317, EFO_0008596 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 4.48e-04 | 110 | 95 | 4 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 4.48e-04 | 110 | 95 | 4 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 4.48e-04 | 110 | 95 | 4 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 4.64e-04 | 111 | 95 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | ovary epithelial cancer (is_implicated_in) | 5.54e-04 | 11 | 95 | 2 | DOID:2152 (is_implicated_in) | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 5.68e-04 | 50 | 95 | 3 | EFO_0022303 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 6.02e-04 | 51 | 95 | 3 | EFO_0022302 | |
| Disease | cholesterol to total lipids in small HDL percentage | 6.02e-04 | 51 | 95 | 3 | EFO_0022240 | |
| Disease | glycoprotein measurement | 6.03e-04 | 119 | 95 | 4 | EFO_0004555 | |
| Disease | Intellectual Disability | 6.14e-04 | 447 | 95 | 7 | C3714756 | |
| Disease | colorectal cancer (is_implicated_in) | 6.42e-04 | 121 | 95 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | triglycerides in HDL measurement | 6.74e-04 | 53 | 95 | 3 | EFO_0022317 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 6.74e-04 | 53 | 95 | 3 | EFO_0022286 | |
| Disease | triglycerides in medium HDL measurement | 7.12e-04 | 54 | 95 | 3 | EFO_0022321 | |
| Disease | puberty onset measurement | 7.26e-04 | 125 | 95 | 4 | EFO_0005677 | |
| Disease | triglycerides in very large HDL measurement | 7.51e-04 | 55 | 95 | 3 | EFO_0022324 | |
| Disease | hippocampal atrophy | 7.92e-04 | 56 | 95 | 3 | EFO_0005039 | |
| Disease | triglycerides in LDL measurement | 7.92e-04 | 56 | 95 | 3 | EFO_0022320 | |
| Disease | triglycerides in chylomicrons and extremely large VLDL measurement | 7.92e-04 | 56 | 95 | 3 | EFO_0022316 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 8.02e-04 | 224 | 95 | 5 | EFO_0004530, EFO_0008317 | |
| Disease | verbal-numerical reasoning measurement | 8.64e-04 | 131 | 95 | 4 | EFO_0008394 | |
| Disease | triglycerides in IDL measurement | 8.77e-04 | 58 | 95 | 3 | EFO_0022149 | |
| Disease | nephroblastoma (is_implicated_in) | 9.10e-04 | 14 | 95 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 9.10e-04 | 14 | 95 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | triglycerides to total lipids in small LDL percentage | 9.22e-04 | 59 | 95 | 3 | EFO_0022337 | |
| Disease | concentration of chylomicrons and extremely large VLDL particles measurement | 9.22e-04 | 59 | 95 | 3 | EFO_0022260 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 9.69e-04 | 60 | 95 | 3 | EFO_0021898 | |
| Disease | triglycerides in medium LDL measurement | 1.07e-03 | 62 | 95 | 3 | EFO_0022322 | |
| Disease | total lipids in chylomicrons and extremely large VLDL measurement | 1.07e-03 | 62 | 95 | 3 | EFO_0022306 | |
| Disease | free cholesterol in very large HDL measurement | 1.07e-03 | 62 | 95 | 3 | EFO_0022273 | |
| Disease | free cholesterol in chylomicrons and extremely large VLDL measurement | 1.07e-03 | 62 | 95 | 3 | EFO_0022263 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 1.12e-03 | 63 | 95 | 3 | EFO_0022283 | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 1.12e-03 | 63 | 95 | 3 | EFO_0022292 | |
| Disease | triglycerides in small LDL measurement | 1.22e-03 | 65 | 95 | 3 | EFO_0022323 | |
| Disease | keratoconus | 1.28e-03 | 66 | 95 | 3 | MONDO_0015486 | |
| Disease | triglyceride measurement, phospholipid measurement | 1.29e-03 | 146 | 95 | 4 | EFO_0004530, EFO_0004639 | |
| Disease | Lipidemias | 1.35e-03 | 17 | 95 | 2 | C1706412 | |
| Disease | Hyperlipidemia | 1.35e-03 | 17 | 95 | 2 | C0020473 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 1.43e-03 | 150 | 95 | 4 | EFO_0004611, EFO_0020947 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 1.45e-03 | 69 | 95 | 3 | EFO_0022341 | |
| Disease | facial attractiveness measurement | 1.69e-03 | 19 | 95 | 2 | EFO_0009892 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 1.78e-03 | 74 | 95 | 3 | EFO_0022280 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 1.85e-03 | 75 | 95 | 3 | EFO_0022287 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 1.95e-03 | 274 | 95 | 5 | EFO_0004530, EFO_0004612 | |
| Disease | FEV/FEC ratio | AKAP6 SELPLG HSPG2 DCHS2 ITCH SLC24A3 CRTC1 R3HDM2 REST LRP1 CHST2 | 1.98e-03 | 1228 | 95 | 11 | EFO_0004713 |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.02e-03 | 276 | 95 | 5 | EFO_0004612, EFO_0020943 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 2.07e-03 | 78 | 95 | 3 | EFO_0022187 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 2.07e-03 | 166 | 95 | 4 | EFO_0004530, EFO_0004611 | |
| Disease | chronotype measurement | 2.17e-03 | 882 | 95 | 9 | EFO_0008328 | |
| Disease | urate measurement | 2.39e-03 | 895 | 95 | 9 | EFO_0004531 | |
| Disease | body weight | AKAP6 DOCK1 GON4L CRTC1 ADGRV1 LRP1B PTPRT SLC38A1 SLC38A2 ABCC8 RPA1 | 2.43e-03 | 1261 | 95 | 11 | EFO_0004338 |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.73e-03 | 86 | 95 | 3 | EFO_0008595, EFO_0020945 | |
| Disease | migraine disorder, Headache | 2.73e-03 | 86 | 95 | 3 | HP_0002315, MONDO_0005277 | |
| Disease | coffee consumption measurement | 2.88e-03 | 182 | 95 | 4 | EFO_0006781 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 3.10e-03 | 90 | 95 | 3 | DOID:11832 (biomarker_via_orthology) | |
| Disease | age at menarche | 3.11e-03 | 594 | 95 | 7 | EFO_0004703 | |
| Disease | cortical thickness | 3.11e-03 | 1113 | 95 | 10 | EFO_0004840 | |
| Disease | level of Sterol ester (27:1/18:2) in blood serum | 3.17e-03 | 26 | 95 | 2 | OBA_2045194 | |
| Disease | proline measurement | 3.17e-03 | 26 | 95 | 2 | EFO_0009773 | |
| Disease | migraine disorder, pulse pressure measurement | 3.17e-03 | 26 | 95 | 2 | EFO_0005763, MONDO_0005277 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 3.20e-03 | 91 | 95 | 3 | EFO_0004611, EFO_0005271 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CNSSAMAMIIGASGL | 3001 | Q9NR09 | |
| VMGDGLETSQMSTTQ | 16 | O60885 | |
| MKLLSGESENSGMSQ | 496 | Q86TB3 | |
| REQMMNSSISSGSGS | 561 | Q12959 | |
| ARDSGTGLMMSVNFS | 5521 | Q8WXG9 | |
| NMASLSAMGKSPLSQ | 111 | Q92793 | |
| SAQEGASPASLMAMG | 956 | Q69YQ0 | |
| EQAMTSSEMANSLGL | 131 | P40616 | |
| GQSQLGSMMSSGSQH | 986 | Q9NQ90 | |
| REQSTTMASMGGFGN | 1166 | Q9C0C7 | |
| NMEATGSRATGMEST | 671 | Q8TF21 | |
| IMAAVSGRASAMSNT | 1026 | O75179 | |
| GISGQEGMQAVMSSD | 1071 | O94823 | |
| LSSQRSSMGGQMQGL | 586 | Q9Y2K5 | |
| TGSNMFAMDQGTATL | 1841 | P98160 | |
| QTGMMGTSSHGLATN | 6 | Q8IY17 | |
| FTSSGNIGMALPNDM | 16 | Q13127 | |
| AMNSAMDTTELLGGF | 2091 | Q9NU22 | |
| DGNTINMANMDGSNS | 1711 | Q9NZR2 | |
| MNLGMSSSLNQQGAH | 56 | P43243 | |
| VSMASSGATQAELMT | 591 | Q86UL8 | |
| SDLFDLMGSSQATMT | 421 | Q14677 | |
| SVINSSMAGMAGTGA | 456 | Q86Y46 | |
| STAMQDGSTLGNMTT | 476 | Q9Y692 | |
| SMTNFLLATMSAGNI | 2236 | Q2M2H8 | |
| MANMDGSNRTLLFSG | 1726 | Q07954 | |
| NSQFTMGGPAISMAS | 581 | Q86X55 | |
| MALFSANSIGAMNNS | 11 | Q8NGF0 | |
| MIRFSGTTGQMSDLN | 1156 | P42356 | |
| DSGIQTMTASGSSAM | 1176 | P50851 | |
| TAMQGNMDTASGLLS | 726 | Q6ZVL6 | |
| SAMSSDGSLAENGVM | 1041 | Q9NZB2 | |
| ALMGMCGSRSADNLS | 1046 | P28290 | |
| GMGDMAVSNSIGSNV | 536 | Q9HC58 | |
| MQMSLQGAEFGLAES | 776 | A2A3N6 | |
| TGSFMMVNSSGRASG | 71 | O14522 | |
| GNENMTFMLDESSGL | 1661 | Q6V1P9 | |
| SMDVAAGTASGAKSM | 131 | O75400 | |
| GMTTSVMAQFNLLSS | 56 | O15350 | |
| MSDSGSQLGSMGSLT | 1 | Q96J02 | |
| MSDGLNTLSSFMLAT | 46 | P27694 | |
| NLGTADMATFMVNSL | 491 | Q9Y2V7 | |
| VSQEGLKLSNDMMGS | 1731 | P04114 | |
| DGTMINNAMQADDSG | 2076 | Q6WRI0 | |
| MQSSLELNGMTGADV | 1781 | Q14185 | |
| MNLMGTGRHSSSSLS | 1671 | Q8IZD9 | |
| GLLEQAAASFSMAGM | 1776 | Q96N67 | |
| TLNYSQAAMMGLTGS | 526 | Q6UUV9 | |
| SLDGLNMLSDSSMGL | 591 | Q6UUV7 | |
| MSGNFDLSIEGMSIS | 131 | P17213 | |
| LGMEDTSLSSGMLTQ | 71 | Q3T8J9 | |
| GMLQALITAMGTSSS | 376 | P48664 | |
| TNLGNQESSGMMKLF | 66 | Q96T75 | |
| DGNSLFDSMASGMRL | 336 | P98153 | |
| RSQSSSLLDMGNMSA | 486 | Q9NV70 | |
| SMAAMNKEGGTASVA | 406 | Q6SPF0 | |
| TMLTAISMSAIATNG | 231 | Q9UHW9 | |
| NSTQGLLMAGSVSAM | 96 | Q8WUM9 | |
| TSLEMTMGNALFLDG | 121 | P08185 | |
| MTLSGGGSASDMSGQ | 1 | Q9UJU5 | |
| TMLTAISMSAIATNG | 166 | Q9H2X9 | |
| LANMGNLSTDSAAME | 106 | Q14242 | |
| MASQMLKVSGSATGT | 741 | Q9HCS7 | |
| SLGMASGMSDALRSS | 216 | Q2YD98 | |
| GMGTNMSNYSSSSLL | 541 | Q8WUY3 | |
| SAASRNMSGQVSMGP | 416 | Q9NYJ8 | |
| GGMNEENMTELLSSG | 91 | Q9UL63 | |
| DTSMGNSSSGMARKG | 161 | Q8IZP6 | |
| GMSVFNLSNAIMGSG | 51 | Q8WUX1 | |
| MMSALDLSGNADDGV | 566 | Q9NVN8 | |
| QNSELMSGSMDKGTL | 641 | O14802 | |
| MGSTEDLNSKGSLSM | 386 | O43166 | |
| NGTMDSNGTFVNVTM | 296 | Q9NY46 | |
| SFGMSSFNLSNAIMG | 76 | Q969I6 | |
| MGIMNFTTSGSSGTN | 336 | P08047 | |
| HLSTSNLSMGEMTAG | 401 | Q09428 | |
| MSFTGQMSLDIASSI | 1666 | Q13023 | |
| RGATAATFGTASMSM | 456 | P52594 | |
| MATSGNGQGSTTRMD | 271 | P25054 | |
| MEQFALNMTSGSGSS | 451 | Q9Y4C5 | |
| QSSIAMMGQGSQGSS | 211 | O75177 | |
| NVSMATNTGGMSSMN | 1391 | Q15596 | |
| GQGMLDSMSLAAVNS | 1601 | Q86UP3 | |
| SDNSAGNMAQLSMAS | 276 | O15062 | |
| SKCMMNTLSSTGQGN | 51 | A2RRD8 | |
| NGDSLMFASLMNSES | 466 | Q70EL2 | |
| ANMMAGLSSLSSGFG | 791 | Q7RTX1 | |
| SGSITMQNIGAMSSY | 151 | Q96QD8 | |
| GDSQMMALNSCTTSI | 1726 | O60281 | |
| VSSLSQMISAEGMNA | 646 | Q5SRE5 | |
| TSMAMQAAALGSSIG | 356 | Q02094 | |
| LSDEQSSSQITGGMM | 416 | Q8IYU4 | |
| DSSVGEMMLLAVNGS | 146 | P98182 | |
| SMMSQSMGGDNLSSL | 196 | Q6R2W3 | |
| GNSLSAAELTCGMIM | 101 | O43175 | |
| ASLGSGMFNSPEMQA | 371 | Q9NRR5 | |
| TSLGMSVFNLSNAIM | 71 | Q9H2H9 | |
| LASGTMDSQMLASGT | 866 | P18583 | |
| LASGTMDAQMLASGT | 876 | P18583 | |
| LASGTMDAQMLASST | 886 | P18583 | |
| SMGSTFDMNGSLGCL | 1206 | Q5THJ4 | |
| TLNVSMSAAMAGLNT | 251 | Q13887 | |
| SSQMVLMTSGLGDSL | 296 | Q5JTD7 |